CDSCO working on new Drug and Cosmetics Act; calls for input

By Gareth Macdonald contact

- Last updated on GMT

iStock/ericsphotography
iStock/ericsphotography

Related tags: Pharmacology

Indian regulator CDSCO is developing a new Drug and Cosmetics Act that is more in keeping with the modern pharmaceutical industry.

The agency announced​ it is working on a revision of India’s 71 year old guidance document this month.

It expalined that the idea is to incorporate advances in testing technology and reflect innovations in formulation development.

Specifics of the revision have not been provided, and the Central Drugs Standards Control Organisation (CDSCO) said it wanted input from the pharmaceutical industry and other stakeholders.

Interested parties have until June 20 to contribute.

Process

Work on the revision of the 1945 Drugs and Cosmetics Rules has been ongoing for the past few years.

This work accelerated in December 2014​ when the Indian Government set up a committee to revisit the legislation.

At the time the Ministry of Health and Family Welfare said the aim was to “make these rules contemporary while keeping in view the requirements of quality, safety and efficacy of medical products​.”

Related topics: Markets & Regulations, Regulations

Related news

Show more

Related products

Transforming Clinical Development

Transforming Clinical Development

PerkinElmer | 01-Jun-2021 | Technical / White Paper

The estimated cost of bringing a drug to market in the U.S. according to JAMA is $1 billion.1 The extreme cost of clinical trials urge biopharmaceutical,...

Vaccine Innovation in the Era of COVID19

Vaccine Innovation in the Era of COVID19

Covance Patient Safety | 01-Oct-2020 | Sponsored Link

During this time of worldwide crisis, there is an increasing demand for the acceleration of a vaccination for COVID19. Regardless of the great recent advancements...

Related suppliers

Follow us

Products

View more

Webinars